Donald B Fuller MD
Urologic Cancer
Radiation Oncologist: Genesis Healthcare Partners CyberKnife Centers of San Diego
Join to View Full Profile
3366 5th AveSan Diego, CA 92103
Phone+1 619-230-0400
Fax+1 858-429-7936
Dr. Fuller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Donald Fuller is a radiation oncologist based in San Diego, CA, treating a wide variety of cancers, with subspecialty interest in urologic cancer. He received his medical degree from the University of Washington School of Medicine, completed an internship in internal medicine at Santa Barbara Cottage Hospital, and a residency in radiation oncology at LDS Hospital in Salt Lake City. Dr. Fuller is experienced in the treatment of prostate cancer, with expertise in technologies such as CyberKnife, brachytherapy, IMRT, and IGRT. His research includes publications on high-dose prostate SBRT, advanced prostate brachytherapy techniques, and the use of SBRT for intraprostatic relapse and for high-risk localized prostate carcinoma. Dr. Fuller has participated in clinical trials exploring the use of CyberKnife radiosurgery for prostate cancer. He received the CMS Meaningful Use Stage 1 Certification from Allscripts Professional EHR in 2012-2013.
Education & Training
LDS HospitalResidency, Radiation Oncology, 1985 - 1988
Santa Barbara Cottage HospitalInternship, Internal Medicine, 1984 - 1985
University of Washington School of MedicineClass of 1984
Certifications & Licensure
AZ State Medical License 2017 - 2026
CA State Medical License 1988 - 2025
WI State Medical License 2017 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012-2013
Clinical Trials
- CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry Start of enrollment: 2007 Oct 22
- CyberKnife Radiosurgery for Locally Recurrent Prostate CA Start of enrollment: 2009 Feb 01
- CyberKnife Radiosurgery for Localized Prostatic Carcinoma Start of enrollment: 2006 Mar 01
Publications & Presentations
PubMed
- 7 citationsHigh Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.Donald B Fuller, Tami Crabtree, Brent L Kane, Clinton A Medbery, Robert Pfeffer
Frontiers in Oncology. 2022-01-01 - 3 citationsToxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.Jesus E. Juarez, Tahmineh Romero, Constantine Mantz, Abigail Pepin, Nima Aghdam
Advances in Radiation Oncology. 2021-08-28 - 22 citationsTumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.Trevor J. Royce, Panayiotis Mavroidis, Kyle Wang, Aaron D. Falchook, Nathan C. Sheets
International Journal of Radiation Oncology, Biology, Physics. 2021-05-01
Press Mentions
Largest Prostate SBRT Studies to Date Show Accuray CyberKnife Provides Excellent Survival Rates in Five or Fewer SessionsSeptember 26th, 2018
Accuray Touts High Survival Rate, Low Toxicity in Cyberknife StudiesSeptember 25th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
